ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,702.55
-0.19%
US Tech 100
19,282.72
-0.27%
Dow Jones
42,063.36
0.09%
Brent Oil
74.135
0.00%
Bitcoin
63,174.35
-0.05%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Crossject (ALCJ) Quote

Crossject

Crossject (ALCJ)

EU
2.425
0.05
(2.11%)
Closed September 20 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
2.425
Bid
2.40
Ask
2.43
Volume
48,971
2.37 Day's Range 2.43
1.52 52 Week Range 5.96
Market Cap
89.151M
Previous Close
2.375
Open
2.37
Last Trade
275
@
2.425
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
54,660
Shares Outstanding
36,763,256
Dividend Yield
-
PE Ratio
-10.30
Earnings Per Share (EPS)
-0.24
Revenue
6.51M
Net Profit
-8.64M

About Crossject

Sector
Med, Dental, Hosp Eq-whsl
Industry
Med, Dental, Hosp Eq-whsl
Website
www.crossject.com
Headquarters
Dijon, Cote-d'or, Fra
Founded
-
Crossject is listed in the Med, Dental, Hosp Eq-whsl sector of the Euronext with ticker ALCJ. The last closing price for Crossject was 2.38 €. Over the last year, Crossject shares have traded in a share price range of 1.52 € to 5.96 €.

Crossject currently has 36,763,256 shares outstanding. The market capitalization of Crossject is 87.31 € million. Crossject has a price to earnings ratio (PE ratio) of -10.30.

Ask ADVFN Intelligence (AI)

ALCJ Latest News

More News

Crossject publiera ses résultats financiers du premier semestre et organisera un webcast le 23 Septembre 2024

Crossject publiera ses résultats financiers du premier semestre et organisera un webcast le 23 Septembre 2024 Dijon, France, 17 septembre 2024 - Crossject (ISIN : FR0011716265 ; Euronext : ALCJ...

September 17 2024
UK Regulatory

Crossject to report first-half 2024 financial results and host webcast on September 23, 2024

Crossject to report first-half 2024 financial results and host webcast on September 23, 2024 Dijon, France, 17 September, 2024 - Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma...

September 17 2024
UK Regulatory

Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright, 9 au 11 septembre 2024

Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright, 9 au 11 septembre 2024 Communiqué de Presse Dijon, France, le 22 août 2024 07:30 CET — Crossject (ISIN :...

August 22 2024
UK Regulatory

Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024

Press Release Dijon, France August 22, 2024 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing medicines for emergency situations harnessing its...

August 22 2024
GlobeNewswire Inc.

Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024

Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024 Press Release Dijon, France August 22, 2024 07:30 CET -- Crossject (ISIN:...

August 22 2024
UK Regulatory

Tony Tipton nommé au poste de directeur des opérations États-Unis de Crossject en vue de la commercialisation de ZEPIZURE®, traitement d'urgence dans la prise en charge des crises d’épilepsie

Tony Tipton nommé au poste de directeur des opérations États-Unis de Crossject en vue de la commercialisation de ZEPIZURE®, traitement d'urgence dans la prise en charge des crises d’épilepsie...

August 19 2024
UK Regulatory

Crossject appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE® Epilepsy Rescue Treatment

Crossject appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE® Epilepsy Rescue Treatment Press Release Crossject appoints Tony Tipton as U.S...

August 19 2024
UK Regulatory

Crossject appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE® Epilepsy Rescue Treatment

Press Release Crossject appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE® Epilepsy Rescue Treatment  Experienced executive to lead...

August 19 2024
GlobeNewswire Inc.

Crossject franchit une nouvelle étape clé dans la fabrication de ZEPIZURE®

Crossject franchit une nouvelle étape clé dans la fabrication de ZEPIZURE® Fabrication réussie d’un autre Lot Règlementaire de ZEPIZURE® sur le nouveau site de fabricationUne étape importante qui...

July 18 2024
UK Regulatory

Crossject achieves key ZEPIZURE® manufacturing milestone

Successful completion of an additional Registration Batch of ZEPIZURE® at new manufacturing siteMilestone complements the satisfying results from previous batches under stability studies, and is...

July 18 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.29513.84976525822.132.432.13527002.32938383DE
40.28513.31775700932.142.4552.07715902.27996092DE
120.68539.3678160921.742.4551.58546602.0397213DE
26-0.875-26.51515151523.33.71.52788492.0880021DE
52-1.45-37.41935483873.8755.961.52801953.25024239DE
156-0.91-27.28635682163.3355.961.408849983.33840853DE
2601.04575.72463768121.385.961.041396103.03400461DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLSMLSmalto
0.018 €
(100.00%)
130.1k
MLPRXParx Materials NV
0.10 €
(66.67%)
36k
ALQGCQuantum Genomics
0.0295 €
(35.94%)
17.64M
CROSCrosswood
8.70 €
(16.00%)
14
ALMDTMedian Technologies
4.505 €
(12.63%)
513.52k
NAIWNew Amsterdam Invest NV
0.05 €
(-44.44%)
721
ALTROTronic s Microsystems
3.70 €
(-32.11%)
304
LIGLisgrafica
0.004 €
(-27.27%)
13.87k
MLUMGUmalis Group
1.37 €
(-19.41%)
33
ALAGOEPango SA
0.223 €
(-18.32%)
1.1M
BCPBanco Comercial Portugues SA
0.4189 €
(0.84%)
74.08M
ALNEVNeovacs
0.0006 €
(0.00%)
59.09M
ALTDTonner Drones
0.0082 €
(-14.58%)
24.89M
AGNAegon Ltd
5.61 €
(-0.43%)
23.84M
KPNKoninklijke KPN NV
3.626 €
(0.53%)
21.47M

Discussion

View Full Feed
Rodney5 Rodney5 1 minute ago
You mean Seeking Garbage. ha
who in their right mind would pay to read it?
FNMA
cojoboy cojoboy 2 minutes ago
The other thing to consider,regardless of what is..or is not happening..retail is Not buying these 10's of millions shares being trading....what it does..or doesn't mean is up to you..????🤔🤔🤔🤔🤔
RONN
meixatech meixatech 3 minutes ago
Extrasynaptic localization is essential for a5GABAA receptor modulation of dopamine system function
Alexandra M McCoy , Thomas D Prevot Md Yeunus Mian , Dishary Sharmin , Adeeba N Ahmad 6, James M Cook , Etienne L Sibille , Daniel J Lodge

DOI: 10.1523/ENEURO.0344-23.2023
RSPI
toohot toohot 3 minutes ago
I see you got the BIEL boot. Too funny!




Where are you going to find entertainment like THIS!
Please, keep those pearls of wisdom coming!

Have an absolutely wonderful weekend!!




BUY $BIEL$
BIEL
BDEZ BDEZ 3 minutes ago
Tell me about it...
BDEZ BDEZ 4 minutes ago
Ok got it thanks buddy, hope they heal and man what a heap of a mess there though.
stock king 1 stock king 1 4 minutes ago
Wow the more we learn about this crooked JK …. Karma always wins in the end
VXIT
gawti88 gawti88 4 minutes ago
Im told its near... and books are in order. But you can listen to tat 4 tity.
CEOS
fuagf fuagf 5 minutes ago
https://www.usnews.com/object/image/00000192-06af-d63b-a592-bfef0ecc0000/mrz091724dapc.jpg?update-time=1726689279209&size=responsiveGallery
SSKILLZ1 SSKILLZ1 5 minutes ago
Points Off Average Victory For 2024

Commentary: Hope Everyone enjoys these statistics
[pre]
Alias # Of Wins Point Off Points Off Average
SSKILLZ1 25 675 27.00
BULLNBEAR52 51 1722 33.76
[/pre]
COMP
mick mick 6 minutes ago
https://www.otcmarkets.com/stock/BQST/profile
BQST
236T568 236T568 6 minutes ago
Oops, ketchup time for the walls of Mar-a-Lago 

https://x.com/flywithkamala/status/1837271296700281133?s=19
joe botts joe botts 7 minutes ago
I mean , I was going to buy like couple hundred dollars worth just to see..
TONR
ChanceVision ChanceVision 8 minutes ago
Etzatlan Processing Plant Under Construction - YouTube Video

https://www.youtube.com/watch?v=Angfs6XjaiM

$AABB
AABB
SSKILLZ1 SSKILLZ1 8 minutes ago
% # Of Wins For 2024

Commentary: Hope Everyone enjoys these statistics.
[pre]
Alias # Of Wins % Of Wins
NO WINNER 105 57.69%
BULLNBEAR52 52 28.57%
SSKILLZ1 25 13.74%
Totals 182 100.00%
[/pre]
COMP
garyhalvo garyhalvo 8 minutes ago
If he skips, he’ll be called Kamala
COOP
SSKILLZ1 SSKILLZ1 9 minutes ago
Points Off Average Victory For September

Commentary: Hope Everyone enjoys these statistics.
[pre]
Alias # Of Wins Point Off Points Off Average
BULLNBEAR52 6 179 29.83
SSKILLZ1 2 82 41.00
[/pre]
COMP
northam43 northam43 9 minutes ago
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/9/20/xymer6.1_Short_Term.png
SSKILLZ1 SSKILLZ1 9 minutes ago
% # Of Wins For September

Commentary: Hope Everyone enjoys these statistics
[pre]
Alias # Of Wins % Of Wins
BULLNBEAR52 6 42.86%
NO WINNER 6 42.86%
SSKILLZ1 2 14.29%
Totals 14 100.00%
[/pre]
COMP
The Whale The Whale 9 minutes ago
Stop scamming people Maryland Boy. People are catching on.
ICTY
cojoboy cojoboy 10 minutes ago
The interesting issues are...no word...pps . goes UP..somewhat.. Positive tweets..pps goes Down..???..smh...Go figure...In for a Penny...In for a Pound..👀👀👀
RONN
Threeflight Threeflight 11 minutes ago
My brother and Linda are actually very similar. Both very narcissistic and full of themselves that live in a reality that is not an actual reality.

In fact Linda used to scream at me via email and even on the phone a few times about how I need to shut my brother up. This was 12 year
DBMM
northam43 northam43 11 minutes ago
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/9/20/xymer6.1_Short_Term.png

Your Recent History

EU
ALCJ
Crossject
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved